Art

J-GLOBAL ID：201302275305987380   Reference number：13A1506863

Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

治療後の最初の4週間における血清KL-6とサーファクタント蛋白質D濃度の顕著な上昇は多発性筋炎/皮膚筋炎と関連した活動性間質性肺炎患者において不良予後を予測する

Author (6)： ARAI Satoko (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN) ,  KURASAWA Kazuhiro (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN) ,  MAEZAWA Reika (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN) ,  OWADA Takayoshi (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN) ,  OKADA Harutsugu (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN) ,  FUKUDA Takeshi (Dokkyo Medical Univ., Clinical Immunology, 880 Kita-Kobayashi, Mibu, 321-0293, Tochigi, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 23  Issue： 5  Page： 872-883  Publication year： Sep. 2013 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *KL-6 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1506863&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (2)： Respiratory system diseases  (GI03000Z) ,  Musculoskeletal diseases  (GG03000T)

Reference (31)：

• MARIE, I. Interstitial lung disease in polymyositis and dematomyositis. Arthritis Rheum. 2002, 47, 614-622
• FATHI, M. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005, 17, 701-706
• NAWATA, Y. Corticosteroid resistant interstitial pneumonitisin dermatomyositis/polymyositis : prediction and treatment with cyclosporine. J Rheumatol. 1999, 26, 1527-1533
• HIRAKATA, M. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000, 12, 501-508
• FATHI, M. Interstitial lung disease, a comon manifestation of newly Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004, 63, 297-301

Terms in the title (10)： 治療 ,  血清 ,  KL-6 ,  サーファクタント蛋白質D ,  多発性筋炎 ,  皮膚筋炎 ,  間質性肺炎 ,  患者 ,  予後 ,  予測